Vanda Pharmaceuticals Inc

Visual Financials
Company Name: Vanda Pharmaceuticals Inc
Ticker Symbol: VNDA
CIK Number: 0001347178
WWW Address: http://www.vandapharma.com
CEO: Dr. Mihael Hristos Polymeropoulos,M.D.
No. of Employees: 142
Common Issue Type: CS
Business Description:Vanda Pharmaceuticals Inc. is a biopharmaceutical Company focusing on the development and commercialization of clinical-stage drug candidates for central nervous system disorders.

 
Industry Information: DRUGS - Biotechnology [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 21.11 Unchanged 0.0 20.58 20.8  21.14 19.70 3571
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 1,107.2 52.4 0.00 -0.35 0.00 0.0 0.0 33.44 - 13.88
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close21.11$
PE Ratio - LTM0.0
Market Capitalisation1,107.2mil
Latest Shares Outstanding52.4mil
Earnings pS (EPS)-0.35$
Dividend pS (DPS)0.00¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee604,700$
Effective Tax Rate0.0%
Float50.9mil
Float as % of Shares Outstanding1.0%
Foreign Salesmil
Domestic Salesmil
Selling, General & Adm/tive (SG&A) as % of Revenue0.80%
Research & Devlopment (R&D) as % of Revenue0.20%
Gross Profit Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Assets Turnover0.0%
Return on Assets (ROA)0.0%
Return on Equity (ROE)0.0%
Return on Capital Invested (ROCI)0.0%
Current Ratio
Leverage Ratio (Assets/Equity)
Interest Cover
Total Debt/Equity (Gearing Ratio)
LT Debt/Total Capital0.0%
Working Capital pS1.90$
Cash pS0.00$
Book-Value pS4.98$
Tangible Book-Value pS2.01$
Cash Flow pS0.36$
Free Cash Flow pS-0.15$
KEY FIGURES (LTM): Price info
Price/Book Ratio3.80
Price/Tangible Book Ratio0.00
Price/Cash Flow52.6
Price/Free Cash Flow
P/E as % of Industry Group0.0%
P/E as % of Sector Segment0.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of Payment-
Dividend Rate0.00
Current Dividend Yield0.0
5-Y Average Dividend Yield0.0
Payout Ratio0.0
5-Y Average Payout Ratio0.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week---11.81,932,686
4 Weeks31.0017.0530.03-33.01,305,89124,811,943
13 Weeks33.4417.0523.60-14.7893,61953,617,171
26 Weeks33.4417.0521.10-4.6915,009113,461,192
52 Weeks33.4413.8817.3016.3743,692185,923,125
YTD31.3917.05--25.51,013,95832,446,687
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
19.2120.4425.9723.0721.690.000.00
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue0.0
Income0.0
Dividend0.0
Capital SpendingNA
R&D5.32NA50.96
Normalized Inc.0.00NA0.00
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %-0.9-0.94.7
Earnings %0.00.00.0
EPS %0.00.00.0
EPS $0.130.13-0.63
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio48.43
Current Ratio2.4
Quick Ratio (Acid Test)2.3
Liquidity Ratio (Cash)2.52
Receivables Turnover8.7
Average Collection Period41
Working Capital/Equity75.7
Working Capital pS2.19
Cash-Flow pS-0.04
Free Cash-Flow pS-0.08
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio9.06
Financial Leverage Ratio (Assets/Equity)0.0
Debt Ratio0.0
Total Debt/Equity (Gearing Ratio)0.00
LT Debt/Equity0.00
LT Debt/Capital Invested2.8
LT Debt/Total Liabilities0.0
Interest Cover0.0
Interest/Capital Invested0.00
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.00
Tobin's Q Ratio4.84
Current P/E Ratio - LTM0.00
Enterprise Value (EV)/EBITDA-64.01
Enterprise Value (EV)/Free Cash Flow-269.25
Dividend Yield0.0
Price/Tangible Book Ratio - LTM0.00
Price/Book Ratio - LTM3.80
Price/Cash Flow Ratio52.6
Price/Free Cash Flow Ratio - LTM
Price/Sales Ratio0.00
P/E Ratio (1 month ago) - LTM0.0
P/E Ratio (26 weeks ago) - LTM0.0
P/E Ratio (52 weeks ago) - LTM0.0
5-Y High P/E Ratio139.3
5-Y Low P/E Ratio28.8
5-Y Average P/E Ratio0.0
Current P/E Ratio as % of 5-Y Average P/E-6
P/E as % of Industry Group0.0
P/E as % of Sector Segment0.0
Current 12 Month Normalized P/E Ratio - LTM0.0
PER SHARE FIGURES
LT Debt pS0.00
Current Liabilities pS1.61
Tangible Book Value pS - LTM2.01
Book Value pS - LTM4.98
Capital Invested pS2.51
Cash pS - LTM0.00
Cash Flow pS - LTM0.36
Free Cash Flow pS - LTM-0.15
Earnings pS (EPS)-0.35
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin-2.21
Free Cash Flow Margin 5YEAR AVG-59.43
Net Profit Margin-0.1
Net Profit Margin - 5YEAR AVRG.
Equity Productivity1.26
Return on Equity (ROE)-0.1
Return on Equity (ROE) - 5YEAR AVRG.
Capital Invested Productivity1.26
Return on Capital Invested (ROCI)-0.2
Return on Capital Invested (ROCI) - 5YEAR AVRG.
Assets Productivity0.80
Return on Assets (ROA)-0.1
Return on Assets (ROA) - 5YEAR AVRG.
Gross Profit Margin0.0
Gross Profit Margin - 5YEAR AVRG.
EBITDA Margin - LTM0.0
EBIT Margin - LTM0.0
Pre-Tax Profit Margin-0.2
Pre-Tax Profit Margin - 5YEAR AVRG.
Effective Tax Rate0.0
Effective Tax Rate - 5YEAR AVRG.0.0
EFFICIENCY RATIOS
Cash Conversion Cycle420,429
Revenue per Employee604,700
Net Income per Employee
Average Collection Period420,429
Receivables Turnover8.7
Day's Inventory Turnover Ratio
Inventory Turnover22.0
Inventory/Sales0.5
Accounts Payble/Sales0.00
Assets/Revenue1.25
Net Working Capital Turnover1.66
Fixed Assets Turnover4.64
Total Assets Turnover0.8
Revenue per $ Cash4.91
Revenue per $ Plant31.11
Revenue per $ Common Equity1.26
Revenue per $ Capital Invested1.26
Selling, General & Adm/tive (SG&A) as % of Revenue75.0
SG&A Expense as % of Revenue - 5YEAR AVRG.0.0
Research & Devlopment (R&D) as % of Revenue23.4
R&D Expense as % of Revenue - 5YEAR AVRG.23.4

  


Your Recent History
NASDAQ
VNDA
Vanda Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.